NASDAQ:RARE - Ultragenyx Pharmaceutical Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$49.22 -1.93 (-3.77 %)
(As of 01/23/2019 04:00 PM ET)
Previous Close$51.15
Today's Range$48.82 - $52.13
52-Week Range$37.44 - $90.98
Volume16,314 shs
Average Volume557,432 shs
Market Capitalization$2.49 billion
P/E Ratio-6.56
Dividend YieldN/A

Analyst Ratings

Ultragenyx Pharmaceutical (NASDAQ:RARE) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
17 Wall Street analysts have issued ratings and price targets for Ultragenyx Pharmaceutical in the last 12 months. Their average twelve-month price target is $76.3750, suggesting that the stock has a possible upside of 55.17%. The high price target for RARE is $95.00 and the low price target for RARE is $54.00. There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.712.782.832.75
Ratings Breakdown: 0 Sell Rating(s)
5 Hold Rating(s)
12 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
14 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
15 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $76.3750$75.3125$85.8667$71.4444
Price Target Upside: 55.17% upside46.84% upside15.77% upside16.16% downside

Ultragenyx Pharmaceutical (NASDAQ:RARE) Consensus Price Target History

Price Target History for Ultragenyx Pharmaceutical (NASDAQ:RARE)

Ultragenyx Pharmaceutical (NASDAQ:RARE) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/23/2019SunTrust BanksBoost Price TargetBuy$71.00HighView Rating Details
1/7/2019WedbushReiterated RatingOutperform$88.00MediumView Rating Details
1/7/2019CowenReiterated RatingBuyMediumView Rating Details
1/4/2019Credit Suisse GroupSet Price TargetHold$59.00MediumView Rating Details
1/2/2019Raymond JamesDowngradeOutperform ➝ Market PerformMediumView Rating Details
11/14/2018JPMorgan Chase & Co.Reiterated RatingBuyMediumView Rating Details
11/8/2018CitigroupUpgradeSell ➝ Neutral$46.00 ➝ $54.00N/AView Rating Details
11/7/2018Canaccord GenuityLower Price TargetBuy$90.00 ➝ $75.00LowView Rating Details
10/29/2018Morgan StanleySet Price TargetHold$92.00 ➝ $70.00HighView Rating Details
10/26/2018Piper Jaffray CompaniesLower Price TargetOverweight$70.00HighView Rating Details
9/11/2018Bank of AmericaBoost Price TargetBuy ➝ Buy$72.00 ➝ $94.00LowView Rating Details
9/2/2018JMP SecuritiesReiterated RatingBuy$94.00MediumView Rating Details
8/3/2018Robert W. BairdReiterated RatingBuy$95.00HighView Rating Details
8/3/2018BarclaysReiterated RatingOverweight ➝ Overweight$74.00 ➝ $92.00HighView Rating Details
7/17/2018Leerink SwannBoost Price TargetOutperform ➝ Outperform$68.00 ➝ $95.00LowView Rating Details
5/10/2018Goldman Sachs GroupInitiated CoverageNeutral ➝ Neutral$63.00MediumView Rating Details
4/18/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$74.00 ➝ $77.00HighView Rating Details
1/22/2018Evercore ISIUpgradeIn-Line ➝ OutperformHighView Rating Details
12/4/2017Jefferies Financial GroupUpgradeHold ➝ Buy$58.00 ➝ $72.00HighView Rating Details
8/8/2017HC WainwrightReiterated RatingNeutral ➝ Neutral$72.00 ➝ $75.00LowView Rating Details
7/27/2017Sanford C. BernsteinInitiated CoverageMarket Perform$72.00HighView Rating Details
(Data available from 1/23/2017 forward)
This page was last updated on 1/23/2019 by Staff

Featured Article: Bid-Ask Spread

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel